Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRADIMED CORP Director's Dealing 2020

Jun 2, 2020

32324_dirs_2020-06-02_16c0678f-baa3-45eb-8066-c9d255c1823c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-05-28

Reporting Person: McDonnell Leslie L (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-28 Common Stock M 101936 Acquired 151936 Direct
2020-05-28 Common Stock F 30603 $22.31 Disposed 121333 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-28 Restricted Stock Units $ M 2867 Disposed Common Stock (7284) Direct
2020-05-28 Restricted Stock Units $ M 27736 Disposed Common Stock (94652) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $21.13 Common Stock (50000) 121333 Direct

Footnotes

F1: As previously disclosed, the reporting person received restricted stock units under the Issuer's 2014 Equity Incentive Plan on August 19, 2019 and December 7, 2019, respectively. Pursuant to the reporting person's employment agreement with the Issuer (the "Employment Agreement"), upon her separation from the issuer without Cause (as defined in the Employment Agreement) on May 28, 2020 (the "Separation Date"), all of her unvested restricted stock units accelerated and vested on the Separation Date as follows: (i) 94,652 unvested restricted stock units accelerated and vested from the August 19, 2019 grant and (ii) 7,284 unvested restricted stock units accelerated and vested from the December 7, 2019 grant (collectively, the "RSUs").

F2: Shares surrendered to the Issuer for payment of tax liability incident to the accelerated vesting of a total of 101,936 restricted stock units.

F3: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F4: All of the unvested RSUs were accelerated on the Separation Date pursuant to the terms of the Employment Agreement.

F5: Pursuant to Employment Agreement, all stock options are fully vested as of the Separation Date.

F6: Pursuant to Employment Agreement, all stock options will expire on August 26, 2020.